Amgen (AMGN)
(Delayed Data from NSDQ)
$269.38 USD
-3.63 (-1.33%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $267.65 -1.73 (-0.64%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth F Momentum D VGM
Average Brokerage Rating
Current ABR | 2.27 |
ABR (Last week) | 2.27 |
# of Recs in ABR | 26 |
Average Target Price | $303.45 |
LT Growth Rate | 5.50% |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 69 of 252 |
Current Quarter EPS Est: | 3.76 |
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 12 | 12 | 12 | 12 | 12 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 10 | 10 | 10 | 9 | 8 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 3 | 3 | 2 | 2 | 2 |
ABR | 2.27 | 2.27 | 2.16 | 2.13 | 2.09 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/12/2024 | Truist Securities | Robyn Karnauskas | Strong Buy | Strong Buy |
3/28/2024 | Raymond James | Gary Nachman | Hold | Hold |
3/7/2024 | Not Identified | Not Identified | Hold | Hold |
2/7/2024 | Robert W. Baird & Co. | Brian P Skorney | Strong Sell | Strong Sell |
2/7/2024 | Piper Sandler | Christopher Raymond | Strong Buy | Strong Buy |
2/7/2024 | SVB Securities | David Risinger | Strong Buy | Hold |
12/21/2023 | Daiwa America | Narumi Nakagiri | Not Available | Strong Buy |
12/19/2023 | BMO Capital Markets | Evan Seigerman | Hold | Strong Buy |
11/3/2023 | William Blair | Matt Phipps | Hold | Hold |
10/17/2023 | Argus Research Corp. | David A Toung | Strong Buy | Strong Buy |
8/14/2023 | Mizuho SecuritiesUSA | Salim Syed | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.